EC Number |
Inhibitors |
Structure |
---|
2.4.1.80 | (+/-)-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
- |
|
2.4.1.80 | (1R)-1-C-octyl-N-octyl-1,5-dideoxy-1,5-imino-D-glucitol |
- |
|
2.4.1.80 | (1R)-N-butyl-1-C-butyl-1,5-dideoxy-1,5-imino-D-glucitol |
- |
|
2.4.1.80 | (1S)-1-C-[5-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin |
- |
|
2.4.1.80 | (1S)-N-butyl-1-C-[5-(adamantan-1-yl-methoxy)-pentyl]-1-deoxynojirimycin |
- |
|
2.4.1.80 | (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol |
i.e. miglitol |
|
2.4.1.80 | (2R,3R,4R,5S)-1-(5-[[3',5'-bis(trifluoromethyl)[1,1'-biphenyl]-4-yl]methoxy]pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol |
- |
|
2.4.1.80 | (2R,3R,4R,5S)-1-(5-[[4-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]methoxy]pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol |
- |
|
2.4.1.80 | (2R,3R,4R,5S)-1-(5-[[4-(2-fluoropyridin-4-yl)phenyl]methoxy]pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol |
- |
|
2.4.1.80 | (2R,3R,4R,5S)-1-(5-[[4-(2H-1,3-benzodioxol-5-yl)phenyl]methoxy]pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol |
- |
|